Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paradefovir vs Tenofovir for Chronic Hepatitis B (Phase II, China)
CTR20180463Phase 2Completed
- Sponsor
- Xi'an Xintong Pharmaceutical Research Co., Ltd.
- Start
- Apr 2018
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pradefovir in Chronic Hepatitis B (CHB), sponsored by Xi'an Xintong Pharmaceutical Research Co., Ltd.. Started Apr 2018; status: completed.
02
Drugs
pradefovir
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on CTR20180463.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20180463.